Harrow Health

$7.86
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.09 (-1.13%) As of 7:40 PM UTC today

Why Robinhood?

You can buy or sell Harrow Health and other stocks, options, and ETFs commission-free!

About HROW

Harrow Health, Inc. engages in the development, production, and sale of innovative medications. It operates through the Pharmaceutical Compounding and Pharmaceutical Drug Development segments. The Pharmaceutical Compounding segment focuses on the operations of ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN. The listed name for HROW is Harrow Health, Inc. Common Stock.

CEO
Mark L. Baum
Employees
133
Headquarters
Nashville, Tennessee
Founded
2006
Market Cap
222.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
267.59K
High Today
$8.27
Low Today
$7.83
Open Price
$8.03
Volume
83.22K
52 Week High
$11.10
52 Week Low
$3.33

HROW Earnings

-$0.50
-$0.23
$0.05
$0.32
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
$0.02 per share
Actual
Available Today, After Hours
Preview Earnings Call

You May Also Like

DHS
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure